Myomembolisation – State of the Art

Kernaussagen

• Die Myomembolisation ist ein etabliertes Alternativverfahren zu den operativen Behandlungsoptionen des symptomatischen Uterus myomatosus.

• Mittels transarterieller Partikelembolisation wird eine Infarzierung der Leiomyome unter Erhalt der Durchblutung des Uterus erreicht, in deren Folge es zur Schrumpfung und Besserung von myomassoziierten Druck- und Blutungsbeschwerden kommt.

• Ziel der Therapie ist die langfristige Kontrolle myombedingter Beschwerden und eine anhaltende Verbesserung der Lebensqualität.

• Literatur

• 1 Day Baird D, Dunson DB, Hill MC et al. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 2003; 188: 100-107
• 2 Gupta S, Jose J, Manyonda I. Clinical presentation of fibroids. Best Pract Res Clin Obstet Gynaecol 2008; 22: 615-626
• 3 Kröncke T, David M. Uterine artery embolization (UAE) for myoma treatment – results of the 3rd radiologic gynecologic expert meeting. Rofo 2010; 182: 615-617
• 4 Spies JB, Myers ER, Worthington-Kirsch R et al. The FIBROID Registry: symptom and quality-of-life status 1 year after therapy. Obstet Gynecol 2005; 106: 1309-1318
• 5 Smeets AJ, Nijenhuis RJ, Boekkooi PF et al. Safety and effectiveness of uterine artery embolization in patients with pedunculated fibroids. J Vasc Interv Radiol 2009; 20: 1172-1175
• 6 Scheurig-Muenkler C, Poellinger A, Wagner M et al. Ovarian artery embolization in patients with collateral supply to symptomatic uterine leiomyomata. Cardiovasc Intervent Radiol 2011; 34: 1199-1207
• 7 Hu NN, Kaw D, McCullough MF et al. Menopause and menopausal symptoms after ovarian artery embolization: a comparison with uterine artery embolization controls. J Vasc Interv Radiol 2011; 22: 710-715
• 8 Mara M, Maskova J, Fucikova Z et al. Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovasc Intervent Radiol 2008; 31: 73-85
• 9 Omary RA, Vasireddy S, Chrisman HB et al. The effect of pelvic MR imaging on the diagnosis and treatment of women with presumed symptomatic uterine fibroids. J Vasc Interv Radiol 2002; 13: 1149-1153
• 10 Rajan DK, Margau R, Kroll RR et al. Clinical utility of ultrasound versus magnetic resonance imaging for deciding to proceed with uterine artery embolization for presumed symptomatic fibroids. Clin Radiol 2011; 66: 57-62
• 11 Spielmann AL, Keogh C, Forster BB et al. Comparison of MRI and sonography in the preliminary evaluation for fibroid embolization. Am J Roentgenol 2006; 187: 1499-1504
• 12 Galvez JA, McCarthy S, Weinreb J et al. Comparison of MRI outcomes of uterine artery embolization for uterine leiomyoma using trisacryl gelatin microspheres, polyvinyl alcohol spheres, and polyvinyl alcohol particles. J Comput Assist Tomogr 2008; 32: 356-361
• 13 Kroencke TJ, Scheurig C, Lampmann LE et al. Acrylamido polyvinyl alcohol microspheres for uterine artery embolization: 12-month clinical and MR imaging results. J Vasc Interv Radiol 2008; 19: 47-57
• 14 Vorwerk D, Rosen T, Keller E et al. Evolution of inflammatory parameters after fibroid embolization. Fortschr Roentgenstr 2003; 175: 253-257
• 15 Spies JB, Spector A, Roth AR et al. Complications after uterine artery embolization for leiomyomas. Obstet Gynecol 2002; 100: 873-880
• 16 Scheurig-Muenkler C, Lembcke A, Froeling V et al. Uterine artery embolization for symptomatic fibroids: long-term changes in disease-specific symptoms and quality of life. Hum Reprod 2011; 36: 2036-2042
• 17 van der Kooij SM, Hehenkamp WJK, Volkers NA et al. Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 5-year outcome from the randomized EMMY trial. Am J Obstet Gynecol 2010; 203: 105-1-q3
• 18 Spies JB, Bruno J, Czeyda-Pommersheim F et al. Long-term outcome of uterine artery embolization of leiomyomata. Obstet Gynecol 2005; 106: 933-939
• 19 Moss JG, Cooper KG, Khaund A et al. Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5-year results. Br J Obstet Gynaecol 2011; 118: 936-944